Shares of Biogen Idec Inc. (Nasdaq: BIIB) are down 25% today following news from the company and partner Elan (NYSE ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE